5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with Hepatitis C in 1 studies
*Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, L; Qu, F; Wan, J; Wu, Q; Xia, Y | 1 |
1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and Hepatitis C
| Article | Year |
|---|---|
Photolabeling probes of ribavirin and EICAR.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Hepacivirus; Hepatitis C; Humans; Imidazoles; Light; Models, Chemical; Models, Molecular; Molecular Biology; Nucleosides; Photoaffinity Labels; Photolysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Time Factors; Triazoles | 2005 |